The transcription factor Fos: a Janus-type regulator in health and disease
Moritz Durchdewald1, Peter Angel, Jochen Hess
1German Cancer Research Center (DKFZ), DKFZ-ZMBH Alliance, Division of Signal Transduction and Growth Control, Heidelberg, Germany.
Abstract:
The immediate early gene product Fos is part of the activator protein-1 (AP-1) transcription factor and has been shown to participate in the molecular mechanisms of cell proliferation, differentiation, apoptosis, and transformation. The analysis of genetically modified mice and cells derived thereof has provided important new insights into its specific biological functions in development, tissue homeostasis, and cellular responses to environmental insults. Moreover, the deregulation of Fos could be linked with a variety of pathological conditions, including immunological, skeletal and neurological defects, as well as oncogenic transformation and tumor progression. In contrast to the mainstream opinion concerning the oncogenic function of Fos an increasing number of experimental reports also describe a tumor-suppressive function in various cancer types. More recently, altered Fos expression in cell culture and mouse models combined with global gene expression analysis unraveled novel downstream effectors of the Fos-regulated genetic program. Finally, selective inhibition of its function with a small molecule inhibitor in a preclinical mouse model of arthritis demonstrated that targeting Fos/AP-1 activity could be an auspicious new option for clinical use.
Insights
The Fos protein, part of the AP-1 transcription factor, plays complex roles in cell functions and diseases. Research reveals both oncogenic and tumor-suppressive roles, with potential for new arthritis treatments.
Area of Science:
- Molecular biology
- Cellular biology
- Genetics
Background:
- The immediate early gene product Fos is a key component of the activator protein-1 (AP-1) transcription factor.
- Fos is implicated in fundamental cellular processes including proliferation, differentiation, apoptosis, and transformation.
Purpose of the Study:
- To investigate the multifaceted biological functions of Fos in development, tissue homeostasis, and cellular responses.
- To explore the dual role of Fos in oncogenic transformation and tumor suppression.
- To identify novel downstream effectors of the Fos-regulated genetic program and assess therapeutic potential.
Main Methods:
- Analysis of genetically modified mice and derived cells.
- Global gene expression analysis in cell culture and mouse models.
- Preclinical studies using small molecule inhibitors in a mouse model of arthritis.
Main Results:
- Genetically modified models provided insights into Fos functions in development and response to insults.
- Fos deregulation is linked to various pathologies, but also exhibits tumor-suppressive functions in certain cancers.
- Novel downstream targets of Fos were identified, and inhibition showed promise in an arthritis model.
Conclusions:
- Fos has complex and context-dependent roles in cellular processes and disease, including both oncogenic and tumor-suppressive activities.
- Targeting Fos/AP-1 activity represents a potential therapeutic strategy for conditions like arthritis.
More Related Videos
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
08:34Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
Published on: June 3, 2016
Related Concept Videos
General Transcription Factors
Master Transcription Regulators
Master Transcription Regulators
Transcription Factors
Transcription Factors
Co-activators and Co-repressors
